Predicting out-of-office blood pressure level using repeated measurements in the clinic: An observational cohort study

Journal of Hypertension

Volumn 32, Issue 11, 2014, Pages 2171-2178

  Sheppard, James P ^a,b   Holder, Roger ^b,c   Nichols, Linda ^b,c   Bray, Emma ^d   Richard Hobbs, F D ^a,b   Mant, Jonathan ^e   Little, Paul ^b,f   Williams, Bryan ^g   Greenfield, Sheila ^b,c   McManus, Richard J ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b University of Manchester   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Home clinic blood pressure difference; Hypertension; Masked effect; Sensitivity; Specificity; White coat effect

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; AMBULATORY MONITORING; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; FEMALE; HOME MONITORING; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MALE; MASKED HYPERTENSION; OBSERVATIONAL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; SELF MONITORING; SENSITIVITY AND SPECIFICITY; SYSTOLIC BLOOD PRESSURE; WHITE COAT HYPERTENSION; COHORT ANALYSIS; MIDDLE AGED; OUTPATIENT DEPARTMENT; PSYCHOLOGY; STATISTICAL MODEL;

ADULT; AGED; AMBULATORY CARE FACILITIES; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; COHORT STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MASKED HYPERTENSION; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; WHITE COAT HYPERTENSION;

EID: 84927598430     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000319     Document Type: Article

References (41)

1. Prospective Studies Collaboration. Age-specific relevance of usual BP to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360:1903-1913.
2. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ. Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet 2002; 360:1347-1360.
3. Lovibond K, Jowett S, Barton P, Caulfield M, Heneghan C, Hobbs FD, et al. Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling study. Lancet 2011; 378:1219-1230.
4. Jin Y, Bies R, Gastonguay MR, Stockbridge N, Gobburu J, Madabushi R. Misclassification and discordance of measured blood pressure from patient's true blood pressure in current clinical practice: a clinical trial simulation case study. J Pharmacokinet Pharmacodyn 2012; 39:283-294.
5. Hodgkinson J, Mant J, Martin U, Guo B, Hobbs FD, Deeks JJ, et al. Relative effectiveness of clinic and home blood pressure monitoring compared with ambulatory blood pressure monitoring in diagnosis of hypertension: systematic review. BMJ 2011; 342:d3621.
6. Pickering TG, Coats A, Mallion JM, Mancia G, Verdecchia P. Blood Pressure Monitoring. Task force V: white-coat hypertension. Blood Press Monit 1999; 4:333-341.
7. Pickering TG, Davidson K, Gerin W, Schwartz JE. Masked hypertension. Hypertension 2002; 40:795-796.
8. Liu JE, Roman MJ, Pini R, Schwartz JE, Pickering TG, Devereux RB. Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure. Ann Intern Med 1999; 131:564-572.
9. Sega R, Trocino G, Lanzarotti A, Carugo S, Cesana G, Schiavina R, et al. Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study). Circulation 2001; 104:1385-1392.
10. Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension 2006; 47:846-853.
11. Ohkubo T, Kikuya M, Metoki H, Asayama K, Obara T, Hashimoto J, et al. Prognosis of 'masked' hypertension and 'white-coat' hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. J Am Coll Cardiol 2005; 46:508-515.
12. Beckett L, Godwin M. The BpTRU automatic blood pressure monitor compared to 24 h ambulatory blood pressure monitoring in the assessment of blood pressure in patients with hypertension. BMC Cardiovasc Disord 2005; 5:18-24.
13. Godwin M, Birtwhistle R, Delva D, Lam M, Casson I, MacDonald S, et al. Manual and automated office measurements in relation to awake ambulatory blood pressure monitoring. Fam Pract 2011; 28:110-117.
14. Myers MG. Automated blood pressure measurement in routine clinical practice. Blood Press Monit 2006; 11:59-62.
15. Myers MG, Godwin M, Dawes M, Kiss A, Tobe SW, Grant FC, et al. Conventional versus automated measurement of blood pressure in primary care patients with systolic hypertension: randomised parallel design controlled trial. Br Med J 2011; 342:d286.
16. Myers MG, Godwin M, Dawes M, Kiss A, Tobe SW, Kaczorowski J. The conventional versus automated measurement of blood pressure in the office (CAMBO) trial: masked hypertension substudy. J Hypertens 2012; 30:1937-1941.
17. McManus R, Mant J, Bray EP, Holder R, Jones MI, Greenfield S, et al. Telemonitoring and self-management in the control of hypertension (TASMINH2): a randomised controlled trial. Lancet 2010; 376:163-172.
18. Mattu GS, Heran BS, Wright JM. Overall accuracy of the BpTRU: an automated electronic blood pressure device. Blood Press Monit 2004; 9:47-52.
19. Mattu GS, Perry TL, Wright JM. Comparison of the oscillometric blood pressure monitor (BPM-100beta) with the auscultatory mercury sphygmomanometer. Blood Press Monit 2001; 6:153-159.
20. Wright JM, Mattu GS, Perry TL, Gelfer ME, Strange KD, Zorn A, et al. Validation of a new algorithm for the BPM-100 electronic oscillometric office blood pressure monitor. Blood Press Monit 2001; 6:161-165.
21. Kannel WB, Gordon T, Schwartz MJ. Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham study. Am J Cardiol 1971; 27:335-346.
22. Rutan GH, Kuller LH, Neaton JD, Wentworth DN, McDonald RH, Smith WM. Mortality associated with diastolic hypertension and isolated systolic hypertension among men screened for the Multiple Risk Factor Intervention Trial. Circulation 1988; 77:504-514.
23. Stergiou GS, Parati G. The optimal schedule for self-monitoring of blood pressure by patients at home. J Hypertens 2007; 25:1992-1997.
24. Wiesel J, Fitzig L, Herschman Y, Messineo FC. Detection of atrial fibrillation using a modified microlife blood pressure monitor. Am J Hypertens 2009; 22:848-852.
25. Pickering TG, Eguchi K, Kario K. Masked hypertension: a review. Hypertens Res 2007; 30:479-488.
26. National Institute for Clinical Excellence. Hypertension: clinical management of primary hypertension in adults. Nice clinical guideline 127. http://www.nice.org.uk/CG127. 2011.
27. MacDonald MB, Laing GP, Wilson MP, Wilson TW. Prevalence and predictors of white-coat response in patients with treated hypertension. CMAJ 1999; 161:265-269.
28. Park SJ, Park JB, Choi DJ, Youn HJ, Park CG, Ahn YK, et al. Detection of masked hypertension and the 'mask effect' in patients with well controlled office blood pressure. Circ J 2011; 75:357-365.
29. Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B, et al. Cardiovascular prognosis of 'masked hypertension' detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA 2004; 291:1342-1349.
30. Obara T, Ohkubo T, Kikuya M, Asayama K, Metoki H, Inoue R, et al. Prevalence of masked uncontrolled and treated white-coat hypertension defined according to the average of morning and evening home blood pressure value: from the Japan Home versus Office Measurement Evaluation Study. Blood Press Monit 2005; 10:311-316.
31. Verdecchia P, Schillaci G, Boldrini F, Zampi I, Porcellati C. Variability between current definitions of 'normal' ambulatory blood pressure. Implications in the assessment of white coat hypertension. Hypertension 1992; 20:555-562.
32. Powers BJ, Olsen MK, Smith VA, Woolson RF, Bosworth HB, Oddone EZ. Measuring blood pressure for decision making and quality reporting: where and how many measures? Ann Intern Med 2011; 154:781-788.
33. Fagard RH, Staessen JA, Thijs L. Prediction of cardiac structure and function by repeated clinic and ambulatory blood pressure. Hypertension 1997; 29:22-29.
34. Imai Y, Ohkubo T, Sakuma M, Tsuji I, Satoh H, Nagai K. Predictive power of screening blood pressure, ambulatory blood pressure and blood pressure measured at home for overall and cardiovascular mortality: a prospective observation in a cohort from Ohasama, northern Japan. Blood Press Monit 1996; 1:251-254.
35. Mancia G, Zanchetti A, Gabiti-Rosei E, Benemio G, De GR, Forgari R. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. SAMPLE Study Group. Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation. Circulation 1997; 95:1464-1470.
36. Ohkubo T, Hozawa A, Nagai K, Kikuya M, Tsuji I, Ito S. Prediction of stroke by ambulatory blood pressure monitoring versus screening blood pressure measurements in a general population: the Ohasama study. J Hypertens 2000; 18:847-854.
37. Staessen JA, Thijs L, Fagard R, O'Brien E, Clement D, de Leeuw P. Predicting cardiovascular risk using conventional vs. ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA 1999; 282:539-546.
38. Verdecchia P, O'Brien E, Pickering T, Staessen JA, Parati G, Myers M, et al. When can the practicing physician suspect white coat hypertension? Statement from the Working Group on Blood Pressure Monitoring of the European Society of Hypertension. Am J Hypertens 2003; 16:87-91.
39. Nasothimiou EG, Tzamouranis D, Rarra V, Roussias LG, Stergiou GS, Nasothimiou EG, et al. Diagnostic accuracy of home vs. ambulatory blood pressure monitoring in untreated and treated hypertension. Hypertens Res 2012; 35:750-755.
40. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013; 34:2159-2219.
41. Myers MG. A proposed algorithm for diagnosing hypertension using automated office blood pressure measurement. J Hypertens 2010; 28:703-708.